CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
An Unusual Case of Fulminant Type 1 Diabetes Developed during Puerperium
P. Shihabudheen, S. K. Suresh Kumar, N. A. Uvais
Korean J Fam Med. 2021;42(3):255-256.   Published online May 20, 2021
DOI: https://doi.org/10.4082/kjfm.21.0040

Excel Download

An Unusual Case of Fulminant Type 1 Diabetes Developed during Puerperium
Korean Journal of Family Medicine. 2021;42(3):255-256   Crossref logo
Link1 Link2 Link3

An Unusual Case of Fulminant Type 1 Diabetes during the Second Trimester of Pregnancy
Case Reports in Obstetrics and Gynecology. 2014;2014:1-4   Crossref logo
Link1 Link2 Link3

Fulminant autoimmune Type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease?
Diabetic Medicine. 2001;18(4):329-332   Crossref logo
Link1 Link2 Link3

Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein-Barr virus that developed in the course of chemotherapy of multiple myeloma
Journal of Diabetes Investigation. 2010;1(6):286-289   Crossref logo
Link1 Link2

Nivolumab
Reactions Weekly. 2017;1654(1):254-254   Crossref logo
Link1 Link2 Link3

2253-PUB: A Rare Case of Fulminant Type 1 Diabetes Postpartum
Diabetes. 2020;69(Supplement_1):   Crossref logo
Link1 Link2

A Case of Fulminant Type 1 Diabetes during Pregnancy
The Journal of Korean Diabetes. 2016;17(2):134   Crossref logo
Link1 Link2 Link3

Fulminant type 1 diabetes mellitus associated with Coxsackievirus type B1 infection during pregnancy: a case report
Journal of Medical Case Reports. 2019;13(1):   Crossref logo
Link1 Link2 Link3

Nivolumab/tozinameran
Reactions Weekly. 2022;1909(1):434-434   Crossref logo
Link1 Link2 Link3

Nivolumab
Reactions Weekly. 2019;1745(1):201-201   Crossref logo
Link1 Link2 Link3